Monopar Therapeutics Inc.

10/27/2021 | Press release | Distributed by Public on 10/27/2021 06:09

Monopar Announces First Patient Dosed in Phase 1b Trial Evaluating Camsirubicin for the Treatment of Advanced Soft Tissue Sarcoma